Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Apr 10;8(1):150.
doi: 10.1038/s41392-023-01424-5.

Control of CAR-T cell activity in space and time: the next level of anti-tumor action

Jessica Hoppstädter  1 , Alexandra K Kiemer  2
Affiliations
Comment

Control of CAR-T cell activity in space and time: the next level of anti-tumor action

Jessica Hoppstädter et al. Signal Transduct Target Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Two novel synthetic biology approaches aim to overcome present limitations of CAR-T cell therapy. Upper panel (1): To overcome tumor microenvironment (TME) suppression of CAR-T cells in solid malignancies, Allen et al. developed circuits in which tumor-specific synthetic Notch (synNotch) receptors locally induced the production of IL-2 trigged by tumor antigens independent from TCR/CAR activation, thereby restricting IL-2 secretion to the tumor site and bypassing the suppressive effects of the TME. Subsequently, autocrine IL-2 signalling promoted CAR-T cell proliferation. This approach increased CAR-T cell infiltration and tumor clearance in immunocompetent models of pancreatic cancer and melanoma. Lower panel (2): Li et al. developed compact synthetic zinc finger transcriptional regulators (synZiFTRs) to control the transcription of therapeutically relevant genes in CAR-T cells using FDA-approved small molecule inducers. In this proof-of-principle study, it was shown that it is possible to instruct T cells by the use of such drugs to sequentially activate multiple cellular programs such as proliferation and antitumor activity. Studies performed in vitro in breast cancer cells and in vivo in immunodeficient mice showed that a sequential induction of superIL-2 (sIL-2, an enhanced version of IL-2 with stronger IL-2 receptor affinity) and CAR can be beneficial for the anti-tumor effect. Created with BioRender.com
See this image and copyright information in PMC

Comment on

References

    1. Allen GM, et al. Synthetic cytokine circuits that drive T cells into immune-excluded tumors. Science. 2022;378:eaba1624. doi: 10.1126/science.aba1624. - DOI - PMC - PubMed
    1. Li H-S, et al. Multidimensional control of therapeutic human cell function with synthetic gene circuits. Science. 2022;378:1227–1234. doi: 10.1126/science.ade0156. - DOI - PMC - PubMed
    1. Good CR, et al. An NK-like CAR T cell transition in CAR T cell dysfunction. Cell. 2021;184:6081–6100.e6026. doi: 10.1016/j.cell.2021.11.016. - DOI - PMC - PubMed
    1. Marofi F, et al. CAR T cells in solid tumors: challenges and opportunities. Stem Cell Res Ther. 2021;12:81. doi: 10.1186/s13287-020-02128-1. - DOI - PMC - PubMed
    1. Roybal KT, et al. Engineering T cells with customized therapeutic response programs using synthetic notch receptors. Cell. 2016;167:419–432.e416. doi: 10.1016/j.cell.2016.09.011. - DOI - PMC - PubMed

Publication types

Substances